HO-4038

structure in first source

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

1.	Bognar, Balazs: 1 article (01/2009)
2.	Carnes, Cynthia A: 1 article (01/2009)
3.	Hideg, Kálmán: 1 article (01/2009)
4.	Khan, Mahmood: 1 article (01/2009)
5.	Kuppusamy, Periannan: 1 article (01/2009)
6.	Kálai, Tamás: 1 article (01/2009)
7.	Mohan, Iyyapu K: 1 article (01/2009)
8.	Selvendiran, Karuppaiyah: 1 article (01/2009)
9.	Sridhar, Arun: 1 article (01/2009)
10.	Wisel, Sheik: 1 article (01/2009)

1.	Myocardial Infarction 01/01/2009 - "Cardioprotection by HO-4038, a novel verapamil derivative, targeted against ischemia and reperfusion-mediated acute myocardial infarction." 01/01/2009 - "In this study, we evaluated the ability of HO-4038, an N-hydroxypiperidine derivative of verapamil, on the modulation of myocardial tissue oxygenation (Po(2)), I/R injury, and key signaling molecules involved in cardioprotection in an in vivo rat model of acute myocardial infarction (MI). "
2.	Ischemia 01/01/2009 - "Verapamil or HO-4038 was infused through the jugular vein 10 min before the induction of ischemia. " 01/01/2009 - "Cardioprotection by HO-4038, a novel verapamil derivative, targeted against ischemia and reperfusion-mediated acute myocardial infarction."
3.	Infarction (Infarctions) 01/01/2009 - "The left ventricular infarct size was significantly less in the HO-4038 (23 +/- 2%) compared with the untreated I/R (36 +/- 4%) group. "